texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Preethi Ramachandran, M.D., MBBS, MRCP, FRCPath(Hematology)

Preethi Ramachandran, M.D., MBBS, MRCP, FRCPath(Hematology) Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Hematology
  • Internal Medicine
  • Medical Oncology

Downloads

General Summary

Dr. Preethi Ramachandran is a board certified physician who has focused her expertise in the field of hematology and oncology. Her specialization is backed by comprehensive training in both the United States and the United Kingdom, granting her a unique perspective and skill set in these disciplines.

After completing her medical degree, Dr. Ramachandran pursued a residency and an extensive five-year fellowship in hematology in the United Kingdom and acquired the prestigious fellowship at the Royal College in London. After her arrival in the United States, she undertook a residency program at Case Western University located in Cleveland, Ohio. This was followed by a specialized fellowship in both hematology and oncology at Brookdale University Hospital and Medical Center, situated in the vibrant setting of New York City. These diverse training experiences have honed her clinical skills and knowledge, equipping her to excel in the fields of hematology and oncology.

Dr. Ramachandran's dedication to education is evident through her passion for teaching, a commitment that she actively upholds. Her involvement in numerous research studies and clinical trials underscores her proactive approach to advancing medical knowledge and treatment methodologies. Her contributions extend to clinical research, where she has delved into the complexities of myeloma, leukemia, lymphomas, and solid tumors. This hands-on engagement in research has culminated in publications that enrich the collective understanding of these critical medical domains. Her multifaceted involvement in education, research, and clinical practice positions her as a respected figure within this field.

Education

USA
  • Fellowship in Medical Oncology and Hematology
    Brookdale University Hospital and Medical Center, Brooklyn, NY
  • Residency in Internal Medicine
    MetroHealth Medical Center, Cleveland, OH
UK
  • Fellowship in Hematology
    Severn Deanery, Bristol, United Kingdom
  • Residency in Internal Medicine
    North Bristol NHS Trust, Bristol, United Kingdom
India
  • Internship in Medicine and Surgery
    Government Kilpauk Medical College, Chennai, India
  • Bachelor of Medicine, Bachelor of Surgery
    The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India

Accolades & Memberships

  • American Society of Hematology
  • American Society of Clinical Oncology
  • American College of Physicians
  • American Medical Association
  • Educational Commission of Foreign Medical Graduates
  • Federation of State Medical Boards
  • Royal College of Pathologists, United Kingdom
  • Royal College of Physicians, United Kingdom
  • General Medical Council, United Kingdom
  • Medical Council of India
  • Tamil Nadu Medical Council, India
  • 5th Annual Brooklyn Research Meeting 2018– Best Hematology Research Poster Award
  • Chief Fellow, Brookdale University Hospital and Medical Center (2019-2020)
  • Chief Fellow, Bristol Hematology and Oncology NHS Trust (2013-2014)
  • Chief Resident, North Bristol NHS Trust (2008-2009)

What is your personal philosophy around patient care?

Dr. Ramachandran is a firm advocate of a holistic approach to patient care, extending beyond the confines of cancer treatment alone. Her philosophy emphasizes the comprehensive well-being of her patients. With a dedication to delivering the highest standard of medical care, she channels her extensive knowledge and experience to provide meticulous attention and treatment.

Central to her practice is the transparent communication of accurate health information to her patients. Dr. Ramachandran ensures that her patients have a clear understanding of their health conditions, fostering an empowered and informed partnership in their healthcare journey.

Recognizing the intricacies of medical care, she places great importance on interdisciplinary collaboration. Dr. Ramachandran champions a multidisciplinary approach, connecting her patients with specialists from various fields to address their unique needs comprehensively.

Her commitment extends further as she consistently applies her skills, clinical acumen, and medical expertise to each patient encounter. Keeping pace with the dynamic medical landscape, she remains updated on the latest advancements and technologies, thereby ensuring that her patients benefit from the forefront of medical progress.

Publications

  • Pre-Hospitalization Proton Pump Inhibitor Use and Clinical Outcomes in COVID-19

    European Journal of Gastroenterology & Hepatology, 2022

  • Red blood cell distribution width in hospitalized COVID-19 patients

    Frontiers in Medicine, 2022

  • High Incidence of Thrombotic Thrombocytopenic Purpura Exacerbation Rate Among Patients With Morbid Obesity and Drug Abuse

    Cureus, 2021

  • Pancytopenia and TTP-Like Picture Secondary to Pernicious Anaemia

    BMJ Case Reports CP, 2020

  • Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019

    Journal of Clinical and Experimental Hepatology, 2020

Show all Publications
  • COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis

    Cancer Control, 2020

  • Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications

    American Journal of Nephrology, 2020

  • Gastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease 2019 Patients

    Digestive Diseases, 2020

  • Low Morbidity and Mortality With COVID-19 in Sickle Cell Disease: A Single Center Experience

    EJHaem, 2020

  • TLR, RAGE, and HMGB1 in the Inflammatory Response in Ph (-) Myeloproliferative Neoplasm

    Blood 136, 2020

  • Polycythemia Vera Presenting With Normal Hemoglobin and Hematocrit: A Rare Variant

    Cureus, 2020

  • Paraneoplastic Pemphigus: An Indication for Treatment in Chronic Lymphocytic Leukemia

    Cureus, 2020

  • Prevalence of Acute Kidney Injury in Myeloma Patients Visiting US Emergency Departments: A Nationwide Analysis

    Journal of Clinical Oncology, 2020

  • Overview of Clinical Characteristics of Patients With TTP (Thrombotic Thrombocytopenic Purpura) in a Low Socioeconomic Population in New York: A 6-Year Center Experience

    British Journal of Haematology, 2020

  • Scalp Metastasis As the First Presentation of an Underlying Aggressive Pancreatic Cancer

    Journal of Investigative Medicine High Impact Case Reports, 2020

  • TTP-Like Syndrome Associated With Hemoglobin SC Disease Treated Successfully With Plasma and Red Cell Exchange

    Leukemia Research Reports, 2019

  • Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay

    The American Journal of Case Reports, 2019

  • Defective Autophagy in Mpn Were Predominantly Detected in Megakaryocytes in Philadelphia Negative (Ph-) Myeloproliferative Neoplasm

    Blood, The Journal of the American Society of Hematology, 2019

  • Unexplained Chronic Cytopenia: Is It Idiopathic Cytopenia of Undetermined Significance or Myelodysplastic Syndrome

    BMJ Case Reports, 2019

  • Gamma-Delta T-Cell Lymphoma: An Overview

    T-cell Lymphomas, 2019

  • Cholangiocarcinoma Presenting As Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review

    Cureus, 2019

  • Tetrasomy 8 Associated With a Poor Prognosis in Acute Monoblastic Leukemia: A Case Report

    Cureus, 2019

  • Fever of Unknown Origin Due to Primary Hepatic Diffuse Large B-Cell Lymphoma: A Case Report

    Cureus, 2019

  • An Unusual Presentation of Merkel Cell Carcinoma in a HIV Patient: A Case Report and Literature Review

    Journal of Investigative Medicine High Impact Case Reports, 2019

  • A Rare Case of Advanced Urethral Diverticular Adenocarcinoma and a Review of Treatment Modalities

    Journal of Investigative Medicine High Impact Case Reports, 2019

  • Quantification of IGF – 1 Receptor Is Useful in the Differential Diagnosis of Essential Thrombocytosis From Reactive Thrombocytosis

    European Journal of Hematology, 2019

  • Sarcoid-Like Reaction Associated With Renal Cell Carcinoma–A Case Report

    Respiratory Medicine Case Reports, 2019

  • Erythrocytosis Is Associated With Intradialytic Hypotension: A Case Series

    BMC Nephrology, 2019

  • De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course

    Journal of Investigative Medicine High Impact Case Reports, 2019

  • Unusual Presentation of Hodgkin Lymphoma With Limbic Encephalitis (Ophelia Syndrome)

    Ann Clin Case Rep. 2016; 1, 2016

  • Alectinib (Alecensa)-Induced Reversible Grade IV Nephrotoxicity: A Case Report and Review of the Literature

    Medical Case Reports, 2012

Medical Practice

  • Stormont Vail Heath, Medical Oncologist and Hematologist, Topeka, KS (August 2022)
  • Belton Regional Medical Center, Director of Medical Oncology and Hematology, Belton, MO (August 2021 – June 2022)
  • Research Medical Center, Medical Oncologist and Hematologist, Kansas City, MO (July 2020 – July 2022)
  • North Bristol NHS Trust, Hematology Specialist Registrar, Bristol, United Kingdom (May 2015 – June 2015)
  • North Bristol NHS Trust (Oct 2009 – May 2015)